Corteva Misses in Brazil-Led Third Quarter as Vylor Holds Its Outlook

A soft Brazil market cut into the crop protection company's first post-separation quarter, while the spun-off seed business pointed to its year-to-date strength and stood by its full-year targets.

Sources

Sources & evidence

What “Source checked” means

CTVALatest quote

Corteva, Inc. reported results

Revenue
$1.59Bbillions USD · Nov. 11, 2026
EPS
$0.08USD per share · Nov. 11, 2026
Data & definitions

Corteva, Inc. results figures used in this article.

Source: Corteva Results Release

Corteva, Inc. reported results — equivalent information
MetricValue
Revenue$1.59B
EPS$0.08

Corteva missed third-quarter expectations on Wednesday as Brazil weakness forced its first standalone guidance reset.

The results, released after Wednesday's close on November 11, 2026, are the first since the October 1, 2026 separation. Corteva is a pure-play crop protection company, and Vylor is the spun-off seed business.

Brazil dragged the quarter lower

Corteva reported third-quarter net sales of $1.59 billion, down 9 percent year over year. The figures are pro forma, restated as if the separation had already happened, in a seasonally smaller quarter.

Organic sales, sales excluding currency and portfolio effects, also fell 9 percent. Volume fell 2 percent and price fell 7 percent.

Latin America sales were $570 million, down 28 percent, and organic sales there fell 31 percent. Latin America was about 36 percent of sales, a TickerGrove calculation.

The company cited elevated channel inventory, delayed purchasing, farmer liquidity constraints and high interest rates in Brazil. Volume there fell 24 percent and price fell 7 percent.

North America sales were $574 million, up 7 percent, with volume up 19 percent. EMEA, Europe, the Middle East and Africa, sales were $239 million, up 12 percent, with organic sales up 14 percent.

Asia Pacific sales were $208 million, up 3 percent.

A GAAP loss beside a small adjusted profit

On a pro forma GAAP basis, Corteva lost $54 million from continuing operations, against income of $60 million a year earlier. The GAAP margin fell 680 basis points, and GAAP earnings per share were a loss of $0.08.

Adjusted operating earnings per share were $0.06, down 57 percent, on the company's adjusted pro forma basis. A basis point is one hundredth of a percentage point.

Adjusted operating EBITDA was $222 million, down 17 percent from $268 million. Its margin narrowed by 140 basis points.

Seeking Alpha reported the $0.06 non-GAAP earnings per share missed expectations by $0.04 and revenue missed by $180 million.

Nine months told a steadier story

For the nine months ended September 30, 2026, net sales were $5.36 billion, down 1 percent. Organic sales fell 4 percent, with volume flat and price down 4 percent.

Pro forma GAAP income was $112 million, a margin of 2.1 percent, with earnings per share of $0.16. Adjusted operating EBITDA was $943 million, flat, and its margin rose 30 basis points to 17.6 percent.

Adjusted operating earnings per share for the nine months were $0.76, up 49 percent.

First standalone guidance replaces the combined range

The outlook below is company guidance and is forward-looking. Corteva expects full-year adjusted pro forma operating EBITDA of $1.1 billion to $1.125 billion.

It expects adjusted pro forma operating earnings per share of $0.76 to $0.80. The range is Corteva's first standalone guidance and replaces the earlier combined-company range.

Nine-month adjusted earnings per share of $0.76 already equal the low end of that range, a TickerGrove calculation. That implies fourth-quarter adjusted earnings per share of $0.00 to $0.04, a TickerGrove calculation.

“Brazil was materially weaker than anticipated,” Chief Executive Luke Kissam said. “While those conditions are reflected in our updated outlook, our strategy has not changed.”

Corteva also expects about $130 million to $140 million in net pre-tax restructuring charges during 2026. The charges cover Crop Protection network optimization, substantially complete in 2028.

Separately, on October 23, 2026, the board authorized Corteva's first common dividend after the spin: $0.05 per share, payable December 15, 2026, to shareholders of record on December 1, 2026.

Vylor held its outlook on year-to-date strength

Vylor, the seed business, reaffirmed its full-year guidance in its own release. Vylor expects adjusted pro forma operating EBITDA of about $2.8 billion and adjusted pro forma operating earnings per share of $2.25 to $2.35.

The reaffirmation rests on nine-month pro forma net sales of $8.53 billion, up 4 percent. Organic sales rose 2 percent over the same period.

Nine-month pro forma GAAP income was $1.01 billion, with earnings per share of $1.50. Adjusted operating EBITDA was $2.66 billion, up 8 percent, and adjusted operating earnings per share were $2.37, up 6 percent.

The third quarter is seasonally Vylor's weakest, because seed sales book mainly in the first half.

Third-quarter pro forma net sales were $938 million, down 1 percent, with organic sales down 3 percent. Volume fell 9 percent, while price and mix rose 6 percent.

Corn sales rose 4 percent to $607 million, while soybean sales fell 26 percent to $133 million.

Americas sales were $613 million, up 3 percent, and Rest of World sales were $325 million, down 7 percent. Americas adjusted segment operating EBITDA improved 19 percent to a loss of $84 million.

On a pro forma GAAP basis, Vylor lost $480 million in the quarter, with a loss per share of $0.72. Adjusted operating EBITDA was a loss of $269 million, down 33 percent, with margin down about 730 basis points.

Adjusted operating earnings per share were a loss of $0.42, down 2 percent.

Chief Executive Chuck Magro said the quarter reinforced the company's confidence in its 2029 framework. “We remain on track to deliver our 2026 commitments,” he said.

On October 22, 2026, Vylor's board authorized a new $3 billion multi-year share repurchase program with no expiration, and a $0.13 per-share dividend, payable December 7, 2026, to shareholders of record on November 30, 2026.

Under its 2029 framework, Vylor targets net sales of about $11.2 billion to $11.9 billion by 2029. It targets operating EBITDA of about $3.3 billion to $3.7 billion and operating EBITDA margins of about 30 percent.

What to watch: Thursday calls and the first market verdict

Vylor discusses its results on Thursday, November 12, 2026, at 9:00 a.m. ET, and Corteva follows at 10:30 a.m. ET. Watch for Brazil outlook, channel inventory detail and 2027 color.

Both releases landed at or after Wednesday's close, so Thursday brings the first market verdict.

What remains unknown

Whether analysts revise their estimates after the prints is not yet known. The fourth-quarter cadence of Brazil purchasing, including how quickly channel inventory clears, also remains unknown.

Corteva's release gives regional detail only, so no segment split is available.

Sources & evidence

Source checked4 sources · 90 figures

Figure receipts

Every figure in this article, with the source it came from.

  • $1.59B Corteva third-quarter pro forma net sales, company-reported

    billions USD · As of Nov. 11, 2026

  • 9 Corteva third-quarter net sales decrease year over year, company-reported

    % · As of Nov. 11, 2026

  • 9 Corteva third-quarter organic sales decrease (company-defined measure), company-reported

    % · As of Nov. 11, 2026

  • 2 Corteva third-quarter volume decrease, company-reported

    % · As of Nov. 11, 2026

  • 7 Corteva third-quarter price decrease, company-reported

    % · As of Nov. 11, 2026

  • $570M Corteva third-quarter Latin America net sales, company-reported

    millions USD · As of Nov. 11, 2026

  • 28 Corteva third-quarter Latin America sales decrease year over year, company-reported

    % · As of Nov. 11, 2026

  • 31 Corteva third-quarter Latin America organic sales decrease, company-reported

    % · As of Nov. 11, 2026

  • 36 Latin America share of Corteva third-quarter sales (TickerGrove calculation: 570 of 1,591)

    % · As of Nov. 11, 2026

  • 24 Corteva third-quarter Latin America volume decrease, company-reported

    % · As of Nov. 11, 2026

  • $574M Corteva third-quarter North America net sales, company-reported

    millions USD · As of Nov. 11, 2026

  • 7 Corteva third-quarter North America sales growth year over year, company-reported

    % · As of Nov. 11, 2026

  • 19 Corteva third-quarter North America volume growth, company-reported

    % · As of Nov. 11, 2026

  • $239M Corteva third-quarter EMEA net sales, company-reported

    millions USD · As of Nov. 11, 2026

  • 12 Corteva third-quarter EMEA sales growth year over year, company-reported

    % · As of Nov. 11, 2026

  • 14 Corteva third-quarter EMEA organic sales growth, company-reported

    % · As of Nov. 11, 2026

  • $208M Corteva third-quarter Asia Pacific net sales, company-reported

    millions USD · As of Nov. 11, 2026

  • 3 Corteva third-quarter Asia Pacific sales growth year over year, company-reported

    % · As of Nov. 11, 2026

  • $54M Corteva third-quarter pro forma GAAP loss from continuing operations, company-reported

    millions USD · As of Nov. 11, 2026

  • $60M Corteva third-quarter 2025 pro forma GAAP income from continuing operations, company-reported

    millions USD · As of Nov. 11, 2026

  • 680 Corteva third-quarter pro forma GAAP margin decline year over year, company-reported

    basis points · As of Nov. 11, 2026

  • $0.08 Corteva third-quarter pro forma GAAP EPS loss per share, company-reported

    USD per share · As of Nov. 11, 2026

  • $0.06 Corteva third-quarter adjusted pro forma operating EPS, company-reported

    USD per share · As of Nov. 11, 2026

  • 57 Corteva third-quarter adjusted pro forma operating EPS decrease year over year, company-reported

    % · As of Nov. 11, 2026

  • $222M Corteva third-quarter adjusted pro forma operating EBITDA, company-reported

    millions USD · As of Nov. 11, 2026

  • 17 Corteva third-quarter adjusted pro forma operating EBITDA decrease year over year, company-reported

    % · As of Nov. 11, 2026

  • $268M Corteva third-quarter 2025 adjusted pro forma operating EBITDA, company-reported

    millions USD · As of Nov. 11, 2026

  • 140 Corteva third-quarter adjusted pro forma operating EBITDA margin erosion year over year, company-reported

    basis points · As of Nov. 11, 2026

  • $5.36B Corteva nine-month pro forma net sales, company-reported

    billions USD · As of Nov. 11, 2026

  • 1 Corteva nine-month net sales decrease year over year, company-reported

    % · As of Nov. 11, 2026

  • 4 Corteva nine-month organic sales decrease, company-reported

    % · As of Nov. 11, 2026

  • 4 Corteva nine-month price decrease, company-reported

    % · As of Nov. 11, 2026

  • $112M Corteva nine-month pro forma GAAP income from continuing operations, company-reported

    millions USD · As of Nov. 11, 2026

  • 2.1 Corteva nine-month pro forma GAAP margin, company-reported

    % · As of Nov. 11, 2026

  • $0.16 Corteva nine-month pro forma GAAP EPS, company-reported

    USD per share · As of Nov. 11, 2026

  • $943M Corteva nine-month adjusted pro forma operating EBITDA, company-reported (flat year over year)

    millions USD · As of Nov. 11, 2026

  • 17.6 Corteva nine-month adjusted pro forma operating EBITDA margin, company-reported

    % · As of Nov. 11, 2026

  • 30 Corteva nine-month adjusted pro forma operating EBITDA margin expansion year over year, company-reported

    basis points · As of Nov. 11, 2026

  • $0.76 Corteva nine-month adjusted pro forma operating EPS, company-reported

    USD per share · As of Nov. 11, 2026

  • 49 Corteva nine-month adjusted pro forma operating EPS growth year over year, company-reported

    % · As of Nov. 11, 2026

  • $1.1B Corteva full-year 2026 adjusted pro forma operating EBITDA guidance, low end (forward-looking company guidance)

    billions USD · As of Nov. 11, 2026

  • $1.13B Corteva full-year 2026 adjusted pro forma operating EBITDA guidance, high end (forward-looking company guidance)

    billions USD · As of Nov. 11, 2026

  • $0.76 Corteva full-year 2026 adjusted pro forma operating EPS guidance, low end (forward-looking company guidance)

    USD per share · As of Nov. 11, 2026

  • $0.80 Corteva full-year 2026 adjusted pro forma operating EPS guidance, high end (forward-looking company guidance)

    USD per share · As of Nov. 11, 2026

  • $0.00 Corteva implied fourth-quarter adjusted operating EPS, low end (TickerGrove calculation: guidance low end 0.76 less nine-month 0.76)

    USD per share · As of Nov. 11, 2026

  • $0.04 Corteva implied fourth-quarter adjusted operating EPS, high end (TickerGrove calculation: guidance high end 0.80 less nine-month 0.76)

    USD per share · As of Nov. 11, 2026

  • $130M Corteva expected 2026 net pre-tax restructuring charges, low end, company-reported

    millions USD · As of Nov. 11, 2026

  • $140M Corteva expected 2026 net pre-tax restructuring charges, high end, company-reported

    millions USD · As of Nov. 11, 2026

  • $2.8B Vylor full-year 2026 adjusted pro forma operating EBITDA guidance, approximately (forward-looking company guidance, reaffirmed)

    billions USD · As of Nov. 11, 2026

  • $2.25 Vylor full-year 2026 adjusted pro forma operating EPS guidance, low end (forward-looking company guidance, reaffirmed)

    USD per share · As of Nov. 11, 2026

  • $2.35 Vylor full-year 2026 adjusted pro forma operating EPS guidance, high end (forward-looking company guidance, reaffirmed)

    USD per share · As of Nov. 11, 2026

  • $8.53B Vylor nine-month pro forma net sales, company-reported

    billions USD · As of Nov. 11, 2026

  • 4 Vylor nine-month pro forma net sales growth year over year, company-reported

    % · As of Nov. 11, 2026

  • 2 Vylor nine-month pro forma organic sales growth, company-reported

    % · As of Nov. 11, 2026

  • $1.01B Vylor nine-month pro forma GAAP income from continuing operations, company-reported

    billions USD · As of Nov. 11, 2026

  • $1.50 Vylor nine-month pro forma GAAP EPS, company-reported

    USD per share · As of Nov. 11, 2026

  • $2.66B Vylor nine-month adjusted pro forma operating EBITDA, company-reported

    billions USD · As of Nov. 11, 2026

  • 8 Vylor nine-month adjusted pro forma operating EBITDA growth year over year, company-reported

    % · As of Nov. 11, 2026

  • $2.37 Vylor nine-month adjusted pro forma operating EPS, company-reported

    USD per share · As of Nov. 11, 2026

  • 6 Vylor nine-month adjusted pro forma operating EPS growth year over year, company-reported

    % · As of Nov. 11, 2026

  • $938M Vylor third-quarter pro forma net sales, company-reported

    millions USD · As of Nov. 11, 2026

  • 1 Vylor third-quarter pro forma net sales decrease year over year, company-reported

    % · As of Nov. 11, 2026

  • 3 Vylor third-quarter pro forma organic sales decrease, company-reported

    % · As of Nov. 11, 2026

  • 9 Vylor third-quarter volume decrease, company-reported

    % · As of Nov. 11, 2026

  • 6 Vylor third-quarter price/mix growth, company-reported

    % · As of Nov. 11, 2026

  • $607M Vylor third-quarter corn pro forma net sales, company-reported

    millions USD · As of Nov. 11, 2026

  • 4 Vylor third-quarter corn sales growth year over year, company-reported

    % · As of Nov. 11, 2026

  • $133M Vylor third-quarter soybean pro forma net sales, company-reported

    millions USD · As of Nov. 11, 2026

  • 26 Vylor third-quarter soybean sales decrease year over year, company-reported

    % · As of Nov. 11, 2026

  • $613M Vylor third-quarter Americas pro forma net sales, company-reported

    millions USD · As of Nov. 11, 2026

  • 3 Vylor third-quarter Americas sales growth year over year, company-reported

    % · As of Nov. 11, 2026

  • $325M Vylor third-quarter Rest of World pro forma net sales, company-reported

    millions USD · As of Nov. 11, 2026

  • 7 Vylor third-quarter Rest of World sales decrease year over year, company-reported

    % · As of Nov. 11, 2026

  • $84M Vylor third-quarter Americas adjusted pro forma segment operating EBITDA loss, company-reported

    millions USD · As of Nov. 11, 2026

  • 19 Vylor third-quarter Americas adjusted segment operating EBITDA improvement year over year, company-reported

    % · As of Nov. 11, 2026

  • $480M Vylor third-quarter pro forma GAAP loss from continuing operations, company-reported

    millions USD · As of Nov. 11, 2026

  • $0.72 Vylor third-quarter pro forma GAAP EPS loss per share, company-reported

    USD per share · As of Nov. 11, 2026

  • $269M Vylor third-quarter adjusted pro forma operating EBITDA loss, company-reported

    millions USD · As of Nov. 11, 2026

  • 33 Vylor third-quarter adjusted pro forma operating EBITDA decline year over year, company-reported

    % · As of Nov. 11, 2026

  • 730 Vylor third-quarter adjusted pro forma operating EBITDA margin decline year over year, company-reported (approximately)

    basis points · As of Nov. 11, 2026

  • $0.42 Vylor third-quarter adjusted pro forma operating EPS loss per share, company-reported

    USD per share · As of Nov. 11, 2026

  • 2 Vylor third-quarter adjusted pro forma operating EPS decrease year over year, company-reported

    % · As of Nov. 11, 2026

  • $3B Vylor new multi-year share repurchase program authorized October 22, 2026, company-reported

    billions USD · As of Nov. 11, 2026

  • $0.13 Vylor quarterly common dividend per share authorized October 22, 2026, company-reported

    USD per share · As of Nov. 11, 2026

  • $11.2B Vylor 2029 framework net sales target, low end (company framework from September 15 Investor Day)

    billions USD · As of Nov. 11, 2026

  • $11.9B Vylor 2029 framework net sales target, high end (company framework from September 15 Investor Day)

    billions USD · As of Nov. 11, 2026

  • $3.3B Vylor 2029 framework operating EBITDA target, low end (company framework)

    billions USD · As of Nov. 11, 2026

  • $3.7B Vylor 2029 framework operating EBITDA target, high end (company framework)

    billions USD · As of Nov. 11, 2026

  • 30 Vylor 2029 framework operating EBITDA margin target, approximately (company framework)

    % · As of Nov. 11, 2026

  • $0.05 Corteva quarterly common dividend per share authorized October 23, 2026, company-reported (Oct 23 release only)

    USD per share · As of Nov. 11, 2026

All dates 2026.

TickerGrove house illustration for commodities coverage: stalks of wheat

Get the Morning Brief — Weekday Morning Brief · Saturday Weekend Brief · Sunday Week Ahead

Discuss this story. Join TickerGrove on Discord to talk companies, earnings, and markets, or request future coverage.

Disclaimer

TickerGrove is education and journalism only. It is not investment advice, not a broker-dealer, and not a recommendation to buy, sell, or hold any security.

Nothing on this site is a pick or a return promise. Official economic prints and company filings are dated observations. External quote links open a separate service; TickerGrove does not host those prices.

Companies · All stories